Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.79% of ...
Edwards Lifesciences' Business In-Depth With that ... surgical clips and inserts. The HemoSphere monitoring platform displays valuable physiological information. Edwards’ latest algorithm ...
HB Wealth Management LLC lowered its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 5.3% in the ...
Bullish option flow detected in Edwards Lifesciences (EW) with 4,815 calls trading, 1.4x expected, and implied vol increasing over 1 point to ...
Edwards Lifesciences EW is developing the most comprehensive structural heart disease portfolio post the sell-off of the Critical Care wing. The Surgical Structural Heart business is benefiting ...
About Edwards Lifesciences Corporation ... Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index ...